Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  12/16/2011
 
Trade Name:  Prezista
 
Generic Name or Proper Name (*):  darunavir
 
Indications Studied:  Treatment of HIV-1 infection in adults and pediatric patients 3 years of age and older and weighing at least 10 kg
 
Label Changes Summary:  Expanded indication to pediatric patients 3 years and older weighing at least 10 kg; previously approved for use in 6 years and olderDo not use in pediatric patients < 3 years of ageInformation on dosing, adverse reactions, pharmacokinetics and clinical trialNew formulation
 
Product Labeling:  Labeling  Opens a new window
 
BPCA(B) and PREA(P):  B, P
 
Sponsor:  Tibotec
 
Pediatric Exclusivity Granted Date:  06/07/2011
 
NNPS:  FALSE'
 
Therapeutic Category:  Antiviral
 
-
-